Insider Transactions in Q4 2025 at Cullinan Oncology, Inc. (CGEM)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 28
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
165,667
+1.81%
|
$1,325,336
$8.4 P/Share
|
|
Oct 17
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
32,217
+0.36%
|
$225,519
$7.84 P/Share
|
|
Oct 16
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
150,000
+1.68%
|
$1,200,000
$8.86 P/Share
|
|
Oct 15
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
51,500
+0.59%
|
$360,500
$7.94 P/Share
|
|
Oct 14
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
15,032
+0.18%
|
$105,224
$7.59 P/Share
|
|
Oct 10
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
277,298
+3.14%
|
$1,941,086
$7.36 P/Share
|
|
Oct 09
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
626,043
+7.04%
|
$3,756,258
$6.7 P/Share
|
|
Oct 08
2025
|
Lynx1 Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
556,300
+6.78%
|
$3,337,800
$6.46 P/Share
|